The Fabry’s disease treatment market is undergoing notable expansion globally, propelled by increased awareness of rare genetic disorders, enhanced diagnostic capabilities, and growing access to advanced therapeutic modalities. As healthcare systems worldwide place a greater emphasis on personalized medicine and rare disease research, the demand for effective enzyme replacement therapies...